3SBio (HKG:1530) is seeking HK$3.12 billion via a stock offering, according to a Hong Kong bourse filing Tuesday.
Shares of the company declined over 4% in Tuesday's morning trade.
The company is seeking investors for around 105.2 million shares priced at HK$29.62 each to raise funds for advancing its drug portfolio.
The shares represent 4.32% of the company's issued share capital and 4.14% as enlarged by the sale.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments